• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Fluorobenzenes

Introduction to 5-(2,6-difluorophenyl)furan-2-carbaldehyde (CAS No. 1094399-13-9)

5-(2,6-difluorophenyl)furan-2-carbaldehyde, identified by the Chemical Abstracts Service Number (CAS No.) 1094399-13-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of furan derivatives, characterized by a five-membered heterocyclic ring containing oxygen, and it is functionalized with an aldehyde group at the 2-position and a 2,6-difluorophenyl substituent at the 5-position. The presence of fluorine atoms introduces unique electronic and steric properties, making this molecule a valuable scaffold for designing novel bioactive agents.

The aldehyde group in 5-(2,6-difluorophenyl)furan-2-carbaldehyde serves as a versatile handle for further chemical modifications, enabling the synthesis of more complex molecules through condensation reactions, oxidation processes, or nucleophilic additions. This reactivity has been exploited in various synthetic pathways to develop pharmacologically relevant derivatives. The 2,6-difluorophenyl moiety enhances the lipophilicity and metabolic stability of the compound, which are critical factors in drug design. Additionally, the electron-withdrawing nature of fluorine atoms can modulate the electronic properties of the aromatic ring, influencing binding interactions with biological targets.

In recent years, there has been growing interest in exploring the pharmacological potential of furan derivatives due to their structural diversity and biological activity. Studies have demonstrated that furan-based compounds exhibit a wide range of biological effects, including antimicrobial, anti-inflammatory, and anticancer properties. The introduction of fluorine substituents further enhances these properties by improving solubility, bioavailability, and target specificity. For instance, 5-(2,6-difluorophenyl)furan-2-carbaldehyde has been investigated as a precursor in the synthesis of kinase inhibitors and other small-molecule drugs targeting cancer-related pathways.

One of the most compelling aspects of 5-(2,6-difluorophenyl)furan-2-carbaldehyde is its utility as an intermediate in the development of novel therapeutic agents. Researchers have leveraged its reactive aldehyde group to construct heterocyclic frameworks that mimic natural products or known drug molecules. This approach has led to the discovery of several promising candidates with improved pharmacokinetic profiles and reduced toxicity. Furthermore, computational studies have suggested that fluorinated furans can exhibit enhanced binding affinity to protein targets due to optimized hydrogen bonding interactions and hydrophobic effects.

The synthesis of 5-(2,6-difluorophenyl)furan-2-carbaldehyde typically involves multi-step organic transformations starting from commercially available precursors such as 2,6-difluorobenzaldehyde and furan derivatives. Advanced synthetic techniques like cross-coupling reactions or palladium-catalyzed transformations have been employed to achieve high yields and purity. The efficiency of these synthetic routes has been optimized through green chemistry principles, minimizing waste and maximizing atom economy. Such advancements underscore the compound's importance as a building block in modern drug discovery.

Recent research highlights have shown that derivatives of 5-(2,6-difluorophenyl)furan-2-carbaldehyde exhibit significant activity against various disease-causing pathogens. For example, studies have reported inhibitory effects on bacterial enzymes involved in DNA replication and transcription. The fluorine atoms play a crucial role in disrupting these enzymatic processes by altering substrate binding affinities. Additionally, preclinical trials have indicated potential therapeutic applications in treating viral infections by targeting viral proteases or polymerases.

The structural features of 5-(2,6-difluorophenyl)furan-2-carbaldehyde make it an attractive candidate for further exploration in medicinal chemistry. Its ability to undergo selective modifications allows chemists to fine-tune its biological activity while maintaining favorable pharmacokinetic properties. This flexibility has led to the development of several lead compounds that are currently undergoing further optimization for clinical use. Collaborative efforts between academia and industry are accelerating the translation of these findings into tangible therapeutic benefits for patients worldwide.

In conclusion,5-(2,6-difluorophenyl)furan-2-carbaldehyde (CAS No. 1094399-13-9) represents a significant advancement in pharmaceutical chemistry due to its unique structural attributes and versatile reactivity. Its role as a key intermediate in drug development underscores its importance in addressing unmet medical needs across multiple therapeutic areas. As research continues to uncover new applications for this compound,5-(2,6-difluorophenyl)furan-2-carbaldehyde is poised to remain at the forefront of innovation in medicinal chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)